{
 "as_of": "2026-11-06",
 "cmr": "uk-cm-kg/AIM/OBI",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# ONDINE BIOMEDICAL INC. (AIM: OBI) — research page\n\nAs of 2026-11-06 · uk-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is ONDINE BIOMEDICAL INC., listed on AIM under ticker OBI, with ISIN CA68234M2058 and LEI 9845005B69E07CGF4A56. Its security type is Corporate and its segment is ASQ1. Its sector is Pharmaceuticals and Biotechnology [201030] and its jurisdiction is CA-BC. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 49 filings in the twelve months to 2026-11-06, across 45 filing days. The median gap between filing days is 4.5 days. The median latency from the latest filing to the record date is 1 day, against an exchange median of 4 days and a sector median of 4.0 days. The exchange median cadence gap is 7.0 days, and the sector median cadence gap is 6.0 days. The latest filing is a regulatory_announcement dated 2026-11-05.\n\n## Auditor\n\nThe auditor of record is PricewaterhouseCoopers LLP. Its location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as the market's register has no lifecycle type map yet. The halt flag shows listed, not halted.\n\n## Orderability\n\nFor the elective professional client category, the signal is ACM-200 and the outcome is determinable. For the eligible counterparty category, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with the chapter as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page.\n\n## Open research\n\nOne openly published research note is on the record, from Edison Investment Research Limited, dated 2023-05-15.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. The live record began on 2026-09-11. The store holds sealed years for the issuer from 2021 through 2026, but these are not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)\n- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/OBI (identity.isin)\n- https://api.gleif.org/api/v1/lei-records/9845005B69E07CGF4A56 (identity.jurisdiction)\n- https://www.londonstockexchange.com/stock/OBI/ondine-biomedical-inc/company-page (identity.sector)\n- https://mcp.uk-cm-kg.ai/events/AIM/OBI (the disclosure lines)\n- https://marketsecurities.fca.org.uk/officiallist (the halt flag)\n- https://ondinebio.com/wp-content/uploads/2025/05/Notice-of-2025-AGM-Important-Notes.pdf (the auditor)\n- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://ondinebio.com/wp-content/uploads/2023/06/Edison-report-2023-05-15-Ondine-Biomedical.pdf (open research)\n- https://mcp.uk-cm-kg.ai/record/AIM/OBI (the record)\n",
 "market": "UK",
 "node": "uk-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-11",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the UK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "Tavily regex",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://ondinebio.com/wp-content/uploads/2025/05/Notice-of-2025-AGM-Important-Notes.pdf",
    "state": "sourced",
    "value": "PricewaterhouseCoopers LLP"
   },
   "auditor_firm_id": {
    "market": "UK",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "UK",
    "state": "not_on_record"
   },
   "changes": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "uk-cm-kg/AIM/OBI",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 594,
     "median_cadence_gap_days": 7,
     "median_filings": 33.5,
     "median_latency_days": 4,
     "name": "AIM"
    },
    "sector": {
     "issuers": 51,
     "median_cadence_gap_days": 6,
     "median_filings": 42,
     "median_latency_days": 4,
     "name": "Pharmaceuticals and Biotechnology [201030]"
    }
   },
   "by_type": {
    "agm_record_date": 2,
    "corporate_action": 3,
    "early_warning": 9,
    "financial_statement": 1,
    "halt_resume": 1,
    "newswire_release": 1,
    "regulatory_announcement": 32
   },
   "cadence_median_gap_days": 4.5,
   "filing_days": 45,
   "filings": 49,
   "latency_days": 1,
   "latest": [
    {
     "category": null,
     "date": "2026-11-05",
     "source": "https://www.investegate.co.uk/announcement/rns/ondine-biomedical-inc-npv-cdi---obi/dartford-and-gravesham-nhs-trust-adopts-steriwave/9859316",
     "title": "Dartford and Gravesham NHS Trust Adopts Steriwave",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-10-28",
     "source": "https://www.investegate.co.uk/announcement/rns/ondine-biomedical-inc-npv-cdi---obi/lantern-safety-results-presented-at-idweek/9844643",
     "title": "LANTERN Safety Results Presented at IDWeek",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-10-26",
     "source": "https://www.investegate.co.uk/announcement/rns/ondine-biomedical-inc-npv-cdi---obi/holding-s-in-company/9842147",
     "title": "Holding(s) in Company",
     "type": "early_warning"
    },
    {
     "category": null,
     "date": "2026-10-23",
     "source": "https://www.investegate.co.uk/announcement/rns/ondine-biomedical-inc-npv-cdi---obi/ottawa-heart-institute-reduces-cabg-ssis-by-51-5-/9837640",
     "title": "Ottawa Heart Institute Reduces CABG SSIs by 51.5%",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-10-20",
     "source": "https://www.investegate.co.uk/announcement/rns/ondine-biomedical-inc-npv-cdi---obi/result-of-fundraise-restoration-of-trading-tvr/9830670",
     "title": "Result of Fundraise, Restoration of Trading & TVR",
     "type": "halt_resume"
    }
   ],
   "latest_filing_date": "2026-11-05",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.uk-cm-kg.ai/events/AIM/OBI",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "AIM"
   },
   "isin": {
    "read_by": "LSE instrument reference record (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/OBI",
    "state": "sourced",
    "value": "CA68234M2058"
   },
   "jurisdiction": {
    "read_by": "GLEIF LEI record (LEI per the LEI column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/9845005B69E07CGF4A56",
    "state": "sourced",
    "value": "CA-BC (CA-BC)"
   },
   "lei": {
    "read_by": "GLEIF name-exact",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/9845005B69E07CGF4A56",
    "state": "filled",
    "value": "9845005B69E07CGF4A56"
   },
   "name": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "ONDINE BIOMEDICAL INC."
   },
   "sector": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/OBI/ondine-biomedical-inc/company-page",
    "state": "sourced",
    "value": "Pharmaceuticals and Biotechnology [201030]"
   },
   "security_type": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "ASQ1"
   },
   "ticker": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "OBI"
   },
   "website": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/OBI/ondine-biomedical-inc/company-page",
    "state": "sourced",
    "value": "https://ondinebio.com/"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "UK",
  "node": "uk-cm-kg",
  "numbers_hash": "sha256:e1042a224505805120e1fd9aa82bd8a22be68057ba94285a8e959bd24762d743",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2023-05-15",
     "kind": "issuer-sponsored",
     "publisher": "Edison Investment Research Limited",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://ondinebio.com/wp-content/uploads/2023/06/Edison-report-2023-05-15-Ondine-Biomedical.pdf",
     "state": "sourced",
     "title": "Initiation - Ondine Biomedical Inc"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "elective professional client",
    "eligible counterparty"
   ],
   "outcomes": {
    "elective professional client": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "eligible counterparty": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.uk-cm-kg.ai/book/aio.json",
    "door": "https://mcp.uk-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/uk/product-governance-fca-prod-sourcebook/r1",
   "section": "uk.aio.v16"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.uk-cm-kg.ai/record/AIM/OBI",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://marketsecurities.fca.org.uk/officiallist",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:e1042a224505805120e1fd9aa82bd8a22be68057ba94285a8e959bd24762d743",
 "path": "/uk/AIM/OBI",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is ONDINE BIOMEDICAL INC., listed on AIM under ticker OBI, with ISIN CA68234M2058 and LEI 9845005B69E07CGF4A56. Its security type is Corporate and its segment is ASQ1. Its sector is Pharmaceuticals and Biotechnology [201030] and its jurisdiction is CA-BC. The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 49 filings in the twelve months to 2026-11-06, across 45 filing days. The median gap between filing days is 4.5 days. The median latency from the latest filing to the record date is 1 day, against an exchange median of 4 days and a sector median of 4.0 days. The exchange median cadence gap is 7.0 days, and the sector median cadence gap is 6.0 days. The latest filing is a regulatory_announcement dated 2026-11-05.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is PricewaterhouseCoopers LLP. Its location is not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as the market's register has no lifecycle type map yet. The halt flag shows listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For the elective professional client category, the signal is ACM-200 and the outcome is determinable. For the eligible counterparty category, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with the chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "One openly published research note is on the record, from Edison Investment Research Limited, dated 2023-05-15.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. The live record began on 2026-09-11. The store holds sealed years for the issuer from 2021 through 2026, but these are not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer"
  },
  {
   "for": "identity.isin",
   "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/OBI"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://api.gleif.org/api/v1/lei-records/9845005B69E07CGF4A56"
  },
  {
   "for": "identity.sector",
   "source": "https://www.londonstockexchange.com/stock/OBI/ondine-biomedical-inc/company-page"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.uk-cm-kg.ai/events/AIM/OBI"
  },
  {
   "for": "the halt flag",
   "source": "https://marketsecurities.fca.org.uk/officiallist"
  },
  {
   "for": "the auditor",
   "source": "https://ondinebio.com/wp-content/uploads/2025/05/Notice-of-2025-AGM-Important-Notes.pdf"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.uk-cm-kg.ai/book/aio.json"
  },
  {
   "for": "open research",
   "source": "https://ondinebio.com/wp-content/uploads/2023/06/Edison-report-2023-05-15-Ondine-Biomedical.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.uk-cm-kg.ai/record/AIM/OBI"
  }
 ],
 "title": "ONDINE BIOMEDICAL INC. (OBI) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}